Cablevision’s support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

 

In His Own Words: Dr. Bert Vogelstein Discusses the Pancreatic Cancer Genome Project

The Pancreatic Cancer Genome Project  was made possible with major funding The Sol Golman Charitable Trust and The Lillian Goldman Charitable Trust, and significant funding from The Lustgarten Foundation.

 

Why did we do the Project?  

 

What did we learn from the Project?

 

How does the Project provide hope?

 

What are the clinical implications of the Project?

Learn more about the Project

 

 

About Bert Vogelstein, M.D.

Dr. Vogelstein's work on the genetic basis of human tumors forms the paradigm for much of modern cancer research, with profound implications for diagnostic and therapeutic strategies of the future. According to the Institute for Scientific Information, he is the most influential scientist in the world. Dr. Vogelstein has received numerous national and international awards for his research and is a member of the American Academy of Arts and Sciences, the European Molecular Biology Organization, the American Philosophical Society, the Institute of Medicine, and the National Academy of Sciences.

Genome Project Named a 2008 "Breakthrough of the Year"

Read more

Genome Project Featured in U.S. News & World Report

Read the article

“Our hope is that sequencing the genome of pancreatic cancers will lead to future areas of research never before possible, including evaluating familial pre-dispositions, developing new diagnostic technologies, and formulating targeted therapeutics.”

- Bert Vogelstein, M.D., Johns Hopkins Kimmel Cancer Center

Join Now

Lustgarten Facebook Lustgarten Twitter Lustgarten YouTube channel

The Lustgarten Foundation
1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303

©2009 Lustgarten Foundation - 501(c)3 - CharityNavigator: 4 Stars